Literature DB >> 24750113

Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda.

Immaculee Mukakalisa1, Ruth Bindler, Carol Allen, Joann Dotson.   

Abstract

In this article we explore literature regarding cervical cancer screening methods available in developing countries. Cervical cancer is a preventable and curable disease, but it continues to threaten the lives of many women. Eighty-five percent of cases and the majority of deaths occur in developing countries. Cytology via Papinicolaou (Pap) smear is not generally a suitable method of screening in low-resource regions. Alternative methods include visual inspection by acetic acid (VIA), human papillomavirus-deoxyribonucleic acid (HPV-DNA), and careHPV-DNA. Education is needed for health care providers and women about preventive immunization and screening. A Rwandan project is described to demonstrate effective program planning and implementation.

Entities:  

Mesh:

Year:  2014        PMID: 24750113     DOI: 10.1080/07399332.2014.909433

Source DB:  PubMed          Journal:  Health Care Women Int        ISSN: 0739-9332


  9 in total

1.  Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.

Authors:  George U Eleje; Ahizechukwu C Eke; Gabriel O Igberase; Anthony O Igwegbe; Lydia I Eleje
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

2.  Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.

Authors:  Fentanesh Nibret Tiruneh; Kun-Yang Chuang; Peter Austin Morton Ntenda; Ying-Chih Chuang
Journal:  BMC Womens Health       Date:  2017-11-15       Impact factor: 2.809

3.  Factors influencing the uptake of cervical cancer screening services in Tanzania: A health system perspective from national and district levels.

Authors:  Anitha M Mugassa; Gasto Frumence
Journal:  Nurs Open       Date:  2019-10-08

4.  Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators.

Authors:  Jacqueline Spayne; Therese Hesketh
Journal:  BMJ Open       Date:  2021-09-02       Impact factor: 2.692

5.  Case study of cervical cancer prevention in two sub-Saharan African countries: Rwanda and Sierra Leone.

Authors:  Mohamed S Bangura; Yuqian Zhao; Maria Jose Gonzalez Mendez; Yixuan Wang; Salah Didier Sama; Kunpeng Xu; Ran Ren; Li Ma; You-Lin Qiao
Journal:  Front Med (Lausanne)       Date:  2022-09-15

Review 6.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

Review 7.  Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies.

Authors:  Amira H Bakir; Martin Skarzynski
Journal:  Front Public Health       Date:  2015-12-17

Review 8.  Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination.

Authors:  Eleanor Black; Robyn Richmond
Journal:  Vaccines (Basel)       Date:  2018-09-08

9.  Multi-Theory Model and Predictors of Likelihood of Accepting the Series of HPV Vaccination: A Cross-Sectional Study among Ghanaian Adolescents.

Authors:  Matthew Asare; Peter Agyei-Baffour; Beth A Lanning; Alex Barimah Owusu; Mary E Commeh; Kathileen Boozer; Adofo Koranteng; Lori A Spies; Jane R Montealegre; Electra D Paskett
Journal:  Int J Environ Res Public Health       Date:  2020-01-16       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.